Documentos relacionados

1. Precise protein conjugation technology for the construction of homogenous glycovaccines.
2. [Vaccines: from the identification of the microorganism to marketing. How long does it take?]
3. Development of a bivalent protein-based vaccine candidate against invasive pneumococcal diseases based on novel pneumococcal surface protein A in combination with pneumococcal histidine triad protein D.
4. Vaccine hesitancy: current and future challenges.
5. Immune responses to bacterial lung infections and their implications for vaccination.
6. Embracing the Diversity of Latinx Communities to Promote Vaccinations.
7. Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines.
8. Epidemiology of pneumococcal diseases in Spain after the introduction of pneumococcal conjugate vaccines
9. Vaccine Hesitancy Under the Magnifying Glass: A Systematic Review of the Uses and Misuses of an Increasingly Popular Construct.
10. Genetic-Code-Expansion Strategies for Vaccine Development.